Complex oncogenic translocations with gene amplification are initiated by specific DNA breaks in lymphocytes

Cancer Research

Volumn 69, Issue 10, 2009, Pages 4454-4460

  Wright, Sarah M ^a   Woo, Yong H ^b   Alley, Travis L ^b   Shirley, Bobbi Jo ^b   Akeson, Ellen C ^b   Snow, Kathy J ^b   Maas, Sarah A ^c   Elwell, Rachel L ^b   Foreman, Oded ^b   Mills, Kevin D ^b  

^a JOSLIN DIABETES CENTER   (United States)

^b JACKSON LABORATORY   (United States)

^c MOUNT DESERT ISLAND BIOLOGICAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; TUMOR MARKER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; GENE AMPLIFICATION; GENE LOCUS; GENE REARRANGEMENT; GENE TRANSLOCATION; GENOMIC INSTABILITY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL;

ANIMALS; CHROMOSOME ABERRATIONS; DISEASE MODELS, ANIMAL; DNA DAMAGE; DNA REPAIR; GENE AMPLIFICATION; GENE REARRANGEMENT; GENES, MYC; GENETIC PREDISPOSITION TO DISEASE; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN JOINING REGION; LYMPHOCYTES; LYMPHOMA, B-CELL; MICE; RISK FACTORS; TRANSLOCATION, GENETIC;

EID: 66249142348     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4515     Document Type: Article

References (34)

1. Mills KD, Ferguson DO, Alt FW. The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev 2003;194:77-95. (Pubitemid 36886430)
2. Zhu C, Mills KD, Ferguson DO, et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002;109:811-821
3. Rooney S, Sekiguchi J, Whitlow S, et al. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc Natl Acad Sci U S A 2004;101:2410-2415 (Pubitemid 38269325)
4. Rooney S, Chaudhuri J, Alt FW. The role of the nonhomologous end-joining pathway in lymphocyte development. Immunol Rev 2004;200:115-131 (Pubitemid 38998197)
5. Martin-Subero JI, Odero MD, Hernandez R, et al. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas. Genes Chromosomes Cancer 2005;43:414-423 (Pubitemid 40946476)
6. Hu L, Sham JS, Xie D, et al. Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma. Cancer Lett 2007;252:36-42. (Pubitemid 46734553)
7. Windle B, Draper BW, Yin YX, O'Gorman S, Wahl GM. A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Dev 1991;5:160-174 (Pubitemid 21905942)
8. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992;70:937-948
9. Difilippantonio MJ, Petersen S, Chen HT, et al. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J Exp Med 2002;196:469-480
10. Maser RS, DePinho RA. Take care of your chromosomes lest cancer take care of you. Cancer Cell 2003;3:4-6. (Pubitemid 37443886)
11. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002;109:S45-55.
12. Li G, Alt FW, Cheng HL, et al. Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination. Mol Cell 2008;31:631-640
13. Moshous D, Callebaut I, de Chasseval R, et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 2001;105:177-186
14. Dudasova Z, Chovanec M. Artemis, a novel guardian of the genome. Neoplasma 2003;50:311-318
15. Schlissel MS. Does artemis end the hunt for the hairpin-opening activity in V(D)J recombination? Cell 2002;109:1-4.
16. Rooney S, Alt FW, Lombard D, et al. Defective DNA repair and increased genomic instability in Artemis-deficient murine cells. J Exp Med 2003;197:553-565 (Pubitemid 36314651)
17. Woo Y, Wright SM, Maas SA, et al. The nonhomologous end joining factor Artemis suppresses multi-tissue tumor formation and prevents loss of heterozygosity. Oncogene 2007;26:6010-6020 (Pubitemid 47373809)
18. Rooney S, Sekiguchi J, Zhu C, et al. Leaky scid phenotype associated with defective V(D)J coding end processing in Artemis-deficient mice. Mol Cell 2002;10:1379-1390
19. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-221
20. Gu H, Zou YR, Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993;73:1155-1164 (Pubitemid 23180489)
21. Akeson EC, Davisson MT. Mitotic chromosome preparations from mouse cells for karyotyping. Curr Protoc Hum Genet 2001;Chapter 4:Unit4 10.
22. Akeson EC, Donahue LR, Beamer WG, et al. Chromosomal inversion discovered in C3H/HeJ mice. Genomics 2006;87:311-313 (Pubitemid 43117453)
23. Akeson EC, Lambert JP, Narayanswami S, Gardiner K, Bechtel LJ, Davisson MT. Ts65Dn - localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome. Cytogenet Cell Genet 2001;93:270-276 (Pubitemid 32799817)
24. Chowdhury D, Sen R. Regulation of immunoglobulin heavy-chain gene rearrangements. Immunol Rev 2004;200:182-196 (Pubitemid 38998202)
25. Adams JM, Harris AW, Strasser A, Ogilvy S, Cory S. Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. Oncogene 1999;18:5268-5277 (Pubitemid 29462362)
26. Kuzin, II, Bagaeva L, Young FM, Bottaro A. Requirement for enhancer specificity in immunoglobulin heavy chain locus regulation. J Immunol 2008;180:7443-7450
27. Yan Y, Park SS, Janz S, Eckhardt LA. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3′ regulatory region induces MYC expression at the immature stage of B cell development. Genes Chromosomes Cancer 2007;46:950-959
28. Huye LE, Roth DB. Differential requirements for cis and trans V(D)J cleavage: effects of substrate length. Nucleic Acids Res 2000;28:4903-4911
29. Kim DR, Park SJ, Oettinger MA. V(D)J recombination: site-specific cleavage and repair. Mol Cells 2000;10:367-374
30. Kim DR, Oettinger MA. Functional analysis of coordinated cleavage in V(D)J recombination. Mol Cell Biol 1998;18:4679-4688
31. Ramsden DA, Paull TT, Gellert M. Cell-free V(D)J recombination. Nature 1997;388:488-491
32. Steen SB, Gomelsky L, Roth DB. The 12/23 rule is enforced at the cleavage step of V(D)J recombination in vivo . Genes Cells 1996;1:543-553
33. Davila M, Liu F, Cowell LG, et al. Multiple, conserved cryptic recombination signals in VH gene segments: detection of cleavage products only in pro B cells. J Exp Med 2007;204:3195-3208
34. Zhang M, Swanson PC. V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies. J Biol Chem 2008;283:6717-6727